Experts review clinical cases and best practices for managing relapsed/refractory DLBCL.
EP. 1: Case 1: Relapsed DLBCL, Transplant Eligible
Watch
EP. 2: Case 1: Waiting for FISH Results in DLBCL
EP. 3: Case 1: Identifying Patients for CNS Prophylaxis in DLBCL
EP. 4: Case 1: Outcomes in Chemotherapy-Treated Patients With DLBCL
EP. 5: Case 1: Therapy for Relapsed DLBCL in Transplant-Eligible Patients
EP. 6: Case 1: Trials in CAR T-Cell for Patients With Relapsed/Refractory DLBCL
EP. 7: Case 1: Therapeutic Options After CAR T-Cell in Relapsed/Refractory DLBCL
EP. 8: Case 2: R-CHOP Refractory DLBCL, Transplant Ineligible
EP. 9: Case 2: Therapeutic Options in Patients With Transplant-Ineligible, Treatment-Refractory DLBCL
EP. 10: Case 2: Considerations for Choosing a Second-Line Therapy for DLBCL
EP. 11: Case 2: Phase 2 L-MIND Clinical Trial for Relapsed/Refractory DLBCL
EP. 12: Case 2: Role of L-MIND Regimen as Second-Line Treatment in Transplant Ineligible DLBCL
EP. 13: Case 3: Relapsed DLBCL, Double Hit
EP. 14: Case 3: Later-line Options to Treat Double-Hit DLBCL
EP. 15: Case 3: Pivotal Trials for DLBCL
EP. 16: Case 3: Third-Line Treatment Options for DLBCL
